Small correction Marzan. LL has never said anything about patients in this trial being mesenchymal. It's the 3 yr survivors that have a majority that are free of progression.
You might have meant methylated rather than mesenchymal. It's true that a great majority of 3yr survivors are meth.
Market Data 
Markets 
AI
